Dr Reddy's Labs receives USFDA EIR for Srikakulam facility Ruchika Sharma26 Aug 2022 12:15 PM ISTNew Delhi: Drugmaker, Dr Reddy's Labs, has recently announced that the Company has received the Establishment Inspection Report (EIR) from the US...
Intercept Pharma resolves patent dispute with Dr Reddys Labs over generic Ocaliva Ruchika Sharma19 Aug 2022 3:03 PM ISTHyderabad: Intercept Pharmaceuticals Inc has said it entered into a settlement agreement with Dr Reddy's Laboratories resolving the previously...
Sun Pharma, Dr Reddy's Labs and 2 others recall products in US Ruchika Sharma16 Aug 2022 11:38 AM ISTAs per the USFDA, Sun Pharma is recalling 9,552 bottles of epilepsy treatment drug Divalproex Sodium delayed-release tablets due to "Failed...
Dr Reddy's Labs to acquire Slayback Pharma OTC ophthalmic product rights Ruchika Sharma30 July 2022 4:07 PM ISTSlayback Pharma is the first company to file an ANDA for the private label equivalent for Lumify with the USFDA under Paragraph IV certification.
Dr Reddys launches Bortezomib for Injection in US Rahul Verma29 July 2022 5:09 PM ISTDrugmaker, Dr Reddy's Laboratories Ltd., has announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade (bortezomib)...
Dr Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in US Ruchika Sharma9 July 2022 2:55 PM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has announced the launch of the company's Fesoterodine Fumarate Extended-Release Tablets, a...
USFDA issues 2 observations for Dr Reddy's Labs Srikakulam facility Ruchika Sharma8 July 2022 11:31 AM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories, has recently announced that the United States Food & Drug Administration (USFDA) has...
Dr Reddy's Labs unit inks drug discovery, development pact with EQRx Ruchika Sharma5 July 2022 11:31 AM ISTThe parties would share both fundings for the discovery and development of the programmes and financials resulting from the commercialisation of any...
JB Chemicals acquires 4 pediatric brands from Dr Reddys Roshni Dhar1 July 2022 5:48 PM ISTJ.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has recently announced that the Board of Directors of the company has approved the...
Health Bulletin 1/July/2022 Roshni Dhar1 July 2022 5:24 PM ISTHere are the top health stories for the day:National Doctor's Day: Paying tribute to white coat heroesDoctors' Day is observed in the honour of noted...
Dr Reddys Labs settles patent litigation with Aquestive Therapeutics, Indivior Ruchika Sharma30 Jun 2022 6:15 PM ISTThe said agreement resolves all claims between the parties relating to the company's generic buprenorphine and naloxone sublingual film, 2 mg/0.5 mg,...
JB Pharma acquires 4 pediatric brands from Dr Reddys Ruchika Sharma30 Jun 2022 12:19 PM ISTThe acquisition has been done for a cash consideration of Rs 98.3 crores.
